Soluble urokinase plasminogen activator receptor as a prognostic marker of all-cause and cardiovascular mortality in a black population

被引:46
作者
Botha, Shani [1 ]
Fourie, Carla M. T. [1 ]
Schutte, Rudolph [1 ,2 ]
Eugen-Olsen, Jesper [3 ]
Pretorius, Ronel [4 ]
Schutte, Aletta E. [1 ,2 ]
机构
[1] North West Univ, Hypertens Africa Res Team, ZA-2520 Potchefstroom, South Africa
[2] North West Univ, Fac Hlth Sci, Res Unit Hypertens & Cardiovasc Dis, Med Res Council, ZA-2520 Potchefstroom, South Africa
[3] Copenhagen Univ Hosp, Clin Res Ctr 136, Hvidovre, Denmark
[4] North West Univ, Res Adv Qual Nursing & Midwifery INSINQ, ZA-2520 Potchefstroom, South Africa
基金
新加坡国家研究基金会;
关键词
C-reactive protein; Interleukin-6; Predict; Death; Inflammation; South Africa; C-REACTIVE PROTEIN; CRITICALLY-ILL PATIENTS; PREDICTS MORTALITY; HEMODIALYSIS-PATIENTS; GENERAL-POPULATION; INCOME COUNTRIES; PLASMA-LEVEL; SOUTH-AFRICA; RISK-FACTORS; SUPAR LEVELS;
D O I
10.1016/j.ijcard.2015.03.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Elevated inflammatory markers such as C-reactive protein (CRP) and interleukin-6 (IL-6) are well-known risk factors for cardiovascular mortality. The less familiar marker, soluble urokinase plasminogen activator receptor (suPAR), is known to predict cancer, infections and all-cause mortality. We determined whether suPAR, CRP and IL-6 are predictive of both all-cause and cardiovascular mortality in a black population, highly burdened by cardiovascular disease and HIV infection. Methods: We included 1425 black South Africans, of which 208 died within five years after baseline data collection. EDTA plasma biomarker levelswere determined, while all-cause and cardiovascular mortalitywere used as endpoints. Results: At baseline suPAR, CRP and IL-6 were higher in non-survivors than in survivors (P < 0.001). SuPAR (HR 1.27, 95% CI 1.09-1.48), IL-6 (HR 1.49, 95% CI 1.24-1.78) and CRP (HR 1.39, 95% CI 1.17-1.65) predicted all-causemortality, while only suPAR (HR 1.40, 95% CI 1.04-1.87) and IL-6 (HR 1.61, 95% CI 1.10-2.35) predicted cardiovascular mortality. The prognostic value of suPAR was independent of IL-6 and CRP (P = 0.015). Conclusion: SuPAR predicted both all-cause and cardiovascular mortality, independent of traditional risk factors, HIV and other inflammatory markers, underlining the prognostic value of suPAR in a black population. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:631 / 636
页数:6
相关论文
共 51 条
[31]   C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men [J].
Mendall, MA ;
Strachan, DP ;
Butland, BK ;
Ballam, L ;
Morris, J ;
Sweetnam, PM ;
Elwood, PC .
EUROPEAN HEART JOURNAL, 2000, 21 (19) :1584-1590
[32]   Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia [J].
Molkanen, T. ;
Ruotsalainen, E. ;
Thorball, C. W. ;
Jarvinen, A. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (11) :1417-1424
[33]   Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients [J].
Panichi, V ;
Maggiore, U ;
Taccola, D ;
Migliori, M ;
Rizza, GM ;
Consani, C ;
Bertini, A ;
Sposini, S ;
Perez-Garcia, R ;
Rindi, P ;
Palla, R ;
Tetta, C .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (05) :1154-1160
[34]   Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmo Diet and Cancer Study [J].
Persson, M. ;
Engstrom, G. ;
Bjorkbacka, H. ;
Hedblad, B. .
ATHEROSCLEROSIS, 2012, 220 (02) :502-505
[35]   Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients [J].
Rao, M ;
Guo, DQ ;
Perianayagam, MC ;
Tighiouart, H ;
Jaber, BL ;
Pereira, BJG ;
Balakrishnan, VS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (02) :324-333
[36]   The prognostic value of the suPARnostic® ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms [J].
Schneider, Uffe V. ;
Nielsen, Rikke L. ;
Pedersen, Court ;
Eugen-Olsen, Jesper .
BMC INFECTIOUS DISEASES, 2007, 7
[37]   How much is too much? Interleukin-6 and its signalling in atherosclerosis [J].
Schuett, Harald ;
Luchtefeld, Maren ;
Grothusen, Christina ;
Grote, Karsten ;
Schieffer, Bernhard .
THROMBOSIS AND HAEMOSTASIS, 2009, 102 (02) :215-222
[38]   Are behavioural risk factors to be blamed for the conversion from optimal blood pressure to hypertensive status in Black South Africans? A 5-year prospective study [J].
Schutte, Aletta E. ;
Schutte, Rudolph ;
Huisman, Hugo W. ;
van Rooyen, Johannes M. ;
Fourie, Carla M. T. ;
Malan, Nico T. ;
Malan, Leone ;
Mels, Catharina M. C. ;
Smith, Wayne ;
Moss, Sarah J. ;
Towers, G. Wayne ;
Kruger, H. Salome ;
Wentzel-Viljoen, Edelweiss ;
Vorster, Hester H. ;
Kruger, Annamarie .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2012, 41 (04) :1114-1123
[39]   Exploring soluble urokinase plasminogen activator receptor and its relationship with arterial stiffness in a bi-ethnic population: the SAfrEIC-study [J].
Schutte, Aletta E. ;
Myburgh, Anelda ;
Olsen, Michael H. ;
Eugen-Olsen, Jesper ;
Schutte, Rudolph .
THROMBOSIS RESEARCH, 2012, 130 (02) :273-277
[40]   Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events [J].
Sehestedt, T. ;
Lyngbaek, S. ;
Eugen-Olsen, J. ;
Jeppesen, J. ;
Andersen, O. ;
Hansen, T. W. ;
Linneberg, A. ;
Jorgensen, T. ;
Haugaard, S. B. ;
Olsen, M. H. .
ATHEROSCLEROSIS, 2011, 216 (01) :237-243